Contrast Media Injectors Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033

Contrast Media Injectors Market Insights

The Contrast Media Injectors (CMI) market size was estimated at $1.60 billion in 2023 and is forecast to grow at a CAGR of more than 4% during 2023 and 2033. Contrast media injectors (CMI) are injectors used in radiology to inject contrast media agents into the bloodstream of patients for the clear visualization of various medical conditions and pathologies. These injectors are used in hospitals with X-rays, computed tomography (CT), magnetic resonance imaging (MRI), Angiography Systems, and other scanners.

Contrast Media Injectors Market Outlook 2023-2033 ($ Billion)

Buy The Full Report for More Insights on Contrast Media Injectors Market Forecast, Request Our Free Sample Report

The contrast media injectors market research report has been created to understand market behavior, which will help identify quantitative market trends in the diagnostic imaging therapeutic area. It discusses in detail the impact of COVID-19 on the contrast media injectors market for the year 2020 and beyond.  The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies.

Growing demand for diagnostic imaging procedures will drive the market growth.

• The market for contrast media injectors is driven by sales of diagnostic imaging systems such as MRI and CT scanners, which have been experiencing growth due to aging global populations and the rising prevalence of chronic diseases.
• The market for contrast media injectors is experiencing stable growth globally and high growth in emerging economies like China and India whose health sectors are booming.

Download the Free Report Sample at: https://www.globaldata.com/store/talk-to-us/?report=1923320

Contrast Media Injectors Market Segmentation

Computed Tomography (CT) Injectors category accounted for the largest revenue in 2023.

• In 2023, the Computed Tomography (CT) Injectors segment accounted for the highest revenue share. CT Injectors are devices used in conjunction with CT systems to inject contrast media agents into the bloodstream of patients.

Contrast Media Injectors Market Category Insights, 2023 (%)

Buy the Full Report to Learn More About the Contrast Media Injectors Market Segments Request A Free Report Sample

Asia-Pacific emerged as the largest regional contributor to the market, followed by North America.

• Countries such as India and China are the major drivers for the growth of MRI and CT contrast injectors in the APAC region. The APAC market growth can be attributed to the rise in R&D investments and favorable demographic scenario in China, rising aging population, and increasing cancer incidences in Japan.
• Moreover, technological advancements in the region have resulted in the availability of innovative and economical devices that can provide easy access to the medical market.

Contrast Media Injectors Market Regional Insights, 2023 (%)

Buy the Full Report for More Regional Insights into the Contrast Media Injectors Market  Request A Free Report Sample

Imaxeon Pty Ltd led the Contrast Media Injectors market share in 2023.

• Some of the leading companies in the Contrast Media Injectors market are Imaxeon Pty Ltd, Nemoto Kyorindo Co Ltd, Guerbet SA, Bracco Imaging SpA, Ulrich GmbH & Co KG, Sino Medical-Device Technology Co., Ltd., and Others.
• In 2023, Imaxeon Pty Ltd accounted for the largest revenue share. The company has a wide range of established contrast injector models and accessories.

Contrast Media Injectors Market Company Insights, 2023 (%)

Buy the Full Report to Get Company-Wise Contrast Media Injectors Market Insights, Download a Free Report Sample https://www.globaldata.com/store/talk-to-us/?report=1923320

Key Inclusions in the Report

Currently marketed Contrast Media Injectors and evolving competitive landscape –
–Insightful review of the key industry trends.
Annualized total Contrast Media Injectors market revenue by segment and market outlooks from 2015-2033.
Market-level data on units, average selling prices, and market values.

Global, Regional, and Country level market specific insights –
Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
SWOT analysis for Contrast Media Injectors market.
Competitive dynamics insights and trends provided for the Contrast Media Injectors market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Country specific overview of the healthcare system.
Country specific reimbursement policies.
Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Imaxeon Pty Ltd, Nemoto Kyorindo Co Ltd, Guerbet SA, Bracco Imaging SpA, Ulrich GmbH & Co KG, Sino Medical-Device Technology Co., Ltd., and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –

• CMO executives who must have a deep understanding of the Contrast Media Injectors marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives must understand crucial components of the supply base to make decisions about supplier selection and management.
• Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to –

• Understand the impact of COVID-19 on the Contrast Media Injectors market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the Contrast Media Injectors market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Contrast Media Injectors market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Contrast Media Injectors market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.